Viridian Therapeutics, Inc.VRDNNASDAQ
LOADING
|||
Switch Symbol:
Price to Sales: Premium Valuation
Trending higher, above historical average, strong compound growth.
Left:
||||
Price-to-sales ratio
Latest
4309.19
↑ 426% above average
Average (9y)
819.40
Historical baseline
Range
High:4309.19
Low:3.37
CAGR
+70.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 4309.19 | +38.8% |
| 2023 | 3104.38 | +486.9% |
| 2022 | 528.93 | +565.1% |
| 2021 | 79.53 | +42.7% |
| 2020 | 55.73 | +1552.8% |
| 2019 | 3.37 | -68.5% |
| 2018 | 10.70 | -78.7% |
| 2017 | 50.14 | +208.6% |
| 2016 | 16.25 | -54.6% |
| 2015 | 35.77 | - |